These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma. Lugat A; Drui D; Mirallié E; Kraeber-Bodéré F; Ansquer C Clin Nucl Med; 2019 Sep; 44(9):738-740. PubMed ID: 31306205 [TBL] [Abstract][Full Text] [Related]
23. False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET ( Berends AMA; Kerstens MN; Bolt JW; Links TP; Korpershoek E; de Krijger RR; Walenkamp AME; Noordzij W; van Etten B; Kats-Ugurlu G; Brouwers AH; van der Horst-Schrivers ANA Eur J Endocrinol; 2018 Aug; 179(2):125-133. PubMed ID: 29875288 [TBL] [Abstract][Full Text] [Related]
24. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658 [TBL] [Abstract][Full Text] [Related]
25. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma. van Berkel A; Rao JU; Kusters B; Demir T; Visser E; Mensenkamp AR; van der Laak JA; Oosterwijk E; Lenders JW; Sweep FC; Wevers RA; Hermus AR; Langenhuijsen JF; Kunst DP; Pacak K; Gotthardt M; Timmers HJ J Nucl Med; 2014 Aug; 55(8):1253-9. PubMed ID: 24925884 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors. Barollo S; Bertazza L; Watutantrige-Fernando S; Censi S; Cavedon E; Galuppini F; Pennelli G; Fassina A; Citton M; Rubin B; Pezzani R; Benna C; Opocher G; Iacobone M; Mian C PLoS One; 2016; 11(5):e0156044. PubMed ID: 27224648 [TBL] [Abstract][Full Text] [Related]
27. Adrenal Metastasis of a Poorly Differentiated Adenocarcinoma Mimicking a Pheochromocytoma on 18F-FDOPA PET/CT. Heimburger C; Averous G; Charlin E; Lang H; Kurtz JE; Imperiale A Clin Nucl Med; 2016 Sep; 41(9):691-2. PubMed ID: 27355847 [TBL] [Abstract][Full Text] [Related]
28. Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma. Grouzmann E; Matter M; Bilz S; Herren A; Triponez F; Henzen C; Kim KS; Zulewski H; Buclin T; Brakch N; Abid K J Clin Endocrinol Metab; 2012 Aug; 97(8):2773-81. PubMed ID: 22569243 [TBL] [Abstract][Full Text] [Related]
29. Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome. Pacak K; Eisenhofer G; Ilias I Hormones (Athens); 2009; 8(2):111-6. PubMed ID: 19570738 [TBL] [Abstract][Full Text] [Related]
30. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas. Magnaldi S; Mayerhoefer ME; Khameneh A; Schuetz M; Javor D; Mitterhauser M; Dudczak R; Hacker M; Karanikas G Anticancer Res; 2014 Feb; 34(2):791-5. PubMed ID: 24511014 [TBL] [Abstract][Full Text] [Related]
31. (11)C-hydroxyephedrine positron emission tomography in the postoperative management of pheochromocytoma and paraganglioma. Yamamoto S; Wassberg C; Hellman P; Sundin A Neuroendocrinology; 2014; 100(1):60-70. PubMed ID: 25012453 [TBL] [Abstract][Full Text] [Related]
33. Genetic status determines Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398 [TBL] [Abstract][Full Text] [Related]
34. Early Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961 [TBL] [Abstract][Full Text] [Related]
35. Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging. Cottereau AS; Garcia C; Dousset B; Libe R; Tenenbaum F Clin Nucl Med; 2022 Mar; 47(3):251-252. PubMed ID: 34507330 [TBL] [Abstract][Full Text] [Related]
36. Correlation between the size of pheochromocytoma and the level of metanephrines. Rezkallah E; Elsaify A; Hanna R; Elsaify W Endocr Regul; 2023 Jan; 57(1):183-190. PubMed ID: 37715982 [No Abstract] [Full Text] [Related]
37. The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. Timmers HJ; Hadi M; Carrasquillo JA; Chen CC; Martiniova L; Whatley M; Ling A; Eisenhofer G; Adams KT; Pacak K J Nucl Med; 2007 Oct; 48(10):1599-606. PubMed ID: 17873132 [TBL] [Abstract][Full Text] [Related]
38. A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction. Defeudis G; Fioriti E; Palermo A; Tuccinardi D; Minucci A; Capoluongo E; Pozzilli P; Manfrini S Hormones (Athens); 2018 Jun; 17(2):279-284. PubMed ID: 29860716 [TBL] [Abstract][Full Text] [Related]
39. Bilateral Adrenal Extremely Intense Metabolic Activity on 18F-FDG PET/CT in a Patient With Pheochromocytomas. Chen X; Chen G; Fu Z; Li Q Clin Nucl Med; 2019 Sep; 44(9):748-749. PubMed ID: 31107752 [TBL] [Abstract][Full Text] [Related]
40. Role of (18) F-FDOPA PET/CT imaging in endocrinology. Santhanam P; Taïeb D Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]